checkAd

     355  0 Kommentare Diabetic Foot Ulcers and Pressure Ulcers Market to Reach US$4.9 Billion by 2024; Immobility in Patients due to Chronic Ailments to Fuel Demand for Treatments, Says TMR

    ALBANY, New York, March 30, 2017 /PRNewswire/ --

    The realm of the global diabetic foot ulcers and pressure ulcers market is helmed by a few players. However, the market exhibits the presence of several large and medium-scale companies, which has rendered its vendor landscape highly competitive. While the dominance has remained with established players having a global presence, they are forecast to witness intense competition at the regional level. These companies are Acelity L.P. Inc., Smith & Nephew Plc, and Molnlycke Health Care AB and together they hold over 50% of the global diabetic foot ulcers and pressure ulcers market in 2015, rendering it a fairly consolidated vendor landscape, finds Transparency Market Research (TMR) in a new study.

    For the companies looking to venture into the market, they might face a tough time establishing a global presence. Furthermore, experts have prophesized the competition to remain high in the market over the next few years, making it even more difficult for new players to establish their presence.

    Browse Market Research Report @ http://www.transparencymarketresearch.com/diabetic-foot-ulcers-pressure-ulcers-market.html

    Overall, the global diabetic foot ulcers and pressure ulcers market will exhibit a positive 6.6% CAGR between 2016 and 2024. At this pace, the market's valuation will reach US$4.9 bn by the end of 2024, from its worth of US$2.8 bn in 2015. Based on end user, hospital inpatient setting will report the maximum demand. It also constituted the leading end user segment in 2015 with a share of 36.1% in the overall market and is forecast to remain at the lead through the forecast period. Regionally, North America emerged dominant with an estimated share of 38.1% in the global market in 2016. The region is expected to remain dominant through the forecast period.

    Rising Incidence of Chronic Ailments to Fuel Market Opportunities 

    According to the Center for Disease Control (CDC), about half of adults in the U.S., were suffering from one or more chronic conditions in 2013. Besides this, the World Health Organization's (WHO's) factsheet says that in 2014, almost 1.9 billion adults were overweight. These health conditions often become a breeding ground for chronic ailments in adults, thereby resulting in their hospital stays, reduced mobility, neuropathic diseases, and other conditions, which are the leading causes of diabetic foot ulcers and pressure ulcers.

    Seite 1 von 3


    PR Newswire (engl.)
    0 Follower
    Autor folgen
    Verfasst von PR Newswire (engl.)
    Diabetic Foot Ulcers and Pressure Ulcers Market to Reach US$4.9 Billion by 2024; Immobility in Patients due to Chronic Ailments to Fuel Demand for Treatments, Says TMR ALBANY, New York, March 30, 2017 /PRNewswire/ - The realm of the global diabetic foot ulcers and pressure ulcers market is helmed by a few players. However, the market exhibits the presence of several large and medium-scale companies, which has …